Vaccinations for children aged five to 11 commence today with parents and carers urged to book their children an appointment as soon as possible.
Premier Dominic Perrottet said the Pfizer COVID-19 vaccine (Comirnaty) will be made available for the roughly 720,000 children in that age group across NSW.
“More than 18,000 kids aged five to 11 have caught COVID-19 since the start of the pandemic, which highlights why vaccination is so important,” Mr Perrottet said.
“We saw a great vaccination response for children aged 12-15 years, so we hope parents will book in their younger children before they start or go back to school.
“I want to also encourage anyone who has not yet received a COVID-19 vaccination to do so. This includes adults who had their second dose four months ago and are now due for a booster.”
Children aged five to 11 will be able to receive their COVID-19 vaccine in a range of centres and local community settings including general practitioners, community pharmacies, NSW Health clinics and other providers such as Aboriginal Medical Services.
NSW Health has so far delivered more than 326,027 booster doses of COVID-19 vaccines, in support of the Federal Government’s vaccine program.
People aged 18 years and older can get a booster at least four months after receiving their second dose of any of the COVID-19 vaccines registered for use in Australia.
Health Minister Brad Hazzard said most parents have always embraced the public health messaging which has helped lift our childhood vaccination rates across NSW.
“Whether it be measles or whooping cough or Pneumococcal or Hepatitis B, parents in NSW have always listened to the science to help protect their kids,” Mr Hazzard said.
“No one wants to see their child in hospital and the best way we can safeguard our kids against COVID-19 and importantly, the elderly around them, is to get them vaccinated.”
NSW Chief Paediatrician Dr Matthew O’Meara said parents should protect their children against the risks of getting COVID-19.
“Everyone who can get vaccinated should get vaccinated whether they’re healthy or not, and it’s especially important for kids who have underlying medical problems or are above a healthy weight.”
Bookings can be made at a NSW Health clinic, GP or pharmacy via the COVID-19 Vaccine Clinic Finder.
Month: January 2022
100 Million Rapid Antigen Tests for NSW
The first batch of 100 million Rapid Antigen Tests (RATs) will be distributed to NSW essential public workers and vulnerable communities from this week to help slow the spread of COVID-19.
Premier Dominic Perrottet said the NSW Government will receive 50 million tests from mid-January to February, with a further 50 million tests being sourced for delivery from February and into March.
“We are ensuring essential workers in our public workforce and vulnerable communities have access to free kits in this first round,” Mr Perrottet said.
“These tests, all approved by the Therapeutic Goods Administration, will help them to quickly ascertain if they need to self-isolate and ensure support and health advice is provided to those who need it.”
Minister for Enterprise, Investment and Trade, Stuart Ayres said the Government’s procurement teams have worked hard to secure tests that meet the TGA’s robust standards.
“The NSW community has one of the highest vaccination rates in the world, which is why we’re able to confidently shift to this new phase of test and isolate.”
“The procurement of these additional rapid antigen tests will support the NSW public sector workforce, support our return to school plan and provide support to those most in need.”
Health Minister Brad Hazzard said the boost to NSW’s RAT supply will help alleviate the pressure on the NSW Health system – as well as provide protection for our most vulnerable.
“Most people should now use a RAT to confirm if they are positive for COVID-19. This allows PCRs to be used when medically required for clinical care, as well as drastically reducing the queues for PCR testing,” Mr Hazzard said.
“While this is an important step in our management of COVID-19, I urgently remind everyone that vaccination and boosters are the best way to keep hospitalisations down and loved ones safe.”
NSW Health and the Department of Communities and Justice will jointly lead distribution of the RATs, with logistical support from NGOs and Primary Health Networks.
Vulnerable populations will be prioritised, including:
- Aboriginal communities
- people receiving aged care services in the home
- people with a disability in supported independent living accommodation
- refugees
- social housing tenants, rough sleepers and women’s refuges
- vulnerable families and children and young people in residential and out-of-home care
Critical government settings have also been prioritised to ensure continuity of essential public services, including return to school, health and transport.
Planning is underway for the rollout of additional tranches of Rapid Antigen Tests in the coming months
More than 42,000 tests are already on their way to 44 Aboriginal Community Controlled Health Services and NGOs supporting rough sleepers and refugees for distribution from tomorrow.
The NSW Government has allocated $250 million to procure the first tranche of 50.1 million RATs.
For more information on rapid antigen testing, please go to:
New program to help parents support their child's mental health
Parents of young children will get help to build their parenting skills under a new Morrison Government-funded national program grant opportunity opening today.
The Parenting Education and Support Program will enable all parents of children up to 11 years of age to develop the confidence and skills they need to support the mental health and wellbeing of their children, including identifying potential problem behaviours early.
Minister for Health and Aged Care Greg Hunt said the program was one of a number of initiatives announced in the 2021-22 Budget in response to key recommendations and actions from the Productivity Commission’s Mental Health Inquiry Report and the Government’s world-first National Children’s Mental Health and Wellbeing Strategy.
“The Parenting Program will offer free, universal, easily accessible, and interactive online parenting education and the Morrison Government is investing $42.3 million over four years from 2021-22 to 2024-25 to make it happen,” Minister Hunt said.
“Our Government will provide funds to an organisation to deliver engaging and interactive parenting resources, strategies and learning tools for parents and carers with a child 0-11 years of age, supported by a national promotion campaign.”
“The Parenting Program will mean more confident parents and carers, and more emotionally well and resilient children. It will improve understanding of children’s mental health and wellbeing, enabling parents and carers to better identify potential behaviour problems, and when and how to access help earlier.”
“The Morrison Government is profoundly committed to protecting the mental health and wellbeing of children and their families – and I am confident the Parenting Program will fill a real need in this area.”
A national study supporting the Children’s Strategy found low levels of child mental health literacy among most Australian parents. It revealed 65% of parents in Australia are not confident they could identify the signs of social or emotional problems in their children and 66% don’t know where to go for help.
Assistant Minister to the Prime Minister for Mental Health and Suicide Prevention David Coleman said a key objective is to reduce stigma when parents and carers ask for help and support for themselves and their children.
“The Parenting Program will become the ‘go to’ online resource for people looking to improve their mental health literacy – a normal, proactive parenting option for parents and carers, both new and experienced,” Assistant Minister Coleman said.
“The Parenting Program will be promoted widely through schools, early learning services, child health and mental health centres, general practitioners, headspace services, Adult Mental Health Centres, Head to Health Kids Hubs and Primary Health Networks.”
“A national multi-media communication campaign will also promote the availability and value of the program, including tackling stigma around participation.”
The Morrison Government is providing unprecedented funding and support for mental health, investing a record $2.3 billion in the National Mental Health and Suicide Prevention Plan to lead landmark reform.
The guidelines for the grant opportunity will be advertised on the GrantConnect website. More information can be found on this website at: www.grants.gov.au
Labor will protect the Great Barrier Reef
An Albanese Labor Government will commit $163 million to conserve the Great Barrier Reef and support the tens of thousands of jobs that depend on it.
The Great Barrier Reef is one of Australia’s national icons. It is central to Queensland life and the Queensland economy. In a normal year, the Reef supports 64,000 jobs and generates $6.4 billion in income.
Preserving national assets like the Great Barrier Reef is an important part of Labor’s plan for a Future Made in Australia.
In protecting the reef, we are also protecting our future.
To immediately boost conservation efforts and jobs, Labor will commit $85 million to scale up ‘shovel-ready’ work for coral to coast reef resilience and land restoration projects in Reef catchments.
To defend the Reef against the risk of being added to the World Heritage ‘in danger’ list, Labor will commit to funding the Reef 2050 program through to the end of the decade, committing an extra $63 million over the forward estimates.
The current Liberal National Government handed almost half a billion dollars to a tiny, ill-equipped, private foundation in a backroom deal, without a tender.
Labor will terminate the much-criticised funding arrangement with that private foundation, and reallocate any unspent funds, while retaining worthwhile programs.
The future of our reef cannot be dependent on a dodgy Liberal jobs-for-mates deal.
Labor will commit $15 million to marine research in the Southern part of the Great Barrier Reef, to scale up the Coastal Marine Ecosystems Research Centre in Gladstone.
The Reef faces significant conservation challenges, in addition to climate change, which remains the greatest threat to Reef health.
Alongside these environmental risks, perceptions about Reef health as well as the COVID-19 pandemic have meant extraordinarily tough times for tourism operators, environmentalists, traditional owners, and regional communities.
The Morrison-Joyce Government has gone missing when it comes to backing North Queensland through this tough time. And they have no plan for what happens next.
Australia’s incredible natural environment is part of who we are as a country and is a drawcard for tourists all over the world. We need to shore up the future of these natural assets just like we do other parts of the economy.
Only an Albanese Labor Government can be trusted to stand up for the Reef and the jobs and communities it supports.
Only Labor will build a better future for Queensland.
Appeal to locate wanted man – Newcastle
Police are appealing for public assistance to locate a man wanted on an outstanding arrest warrant.
Kevin Smith, aged 37, is wanted by virtue of an outstanding arrest warrant for murder.
Officers from Newcastle City Police District and specialist units have commenced inquiries into his whereabouts.
He is described as being of Caucasian appearance, between 180cm to 185cm tall, of thin build, with green eyes, brown hair, a beard and a moustache. He has a distinctive tattoo on the right side of his face.
He is known to frequent the Newcastle area, but has ties to several locations including Sydney and Northern NSW.
Anyone who may have seen Mr Smith is urged not to approach him and to call Triple Zero (000) immediately.
$14.8 million for innovative mental health clinical trials
Seven clinical trials testing the use of potential breakthrough combination therapies to treat debilitating mental illnesses will receive a total of almost $15 million from the Morrison Government’s Medical Research Future Fund (MRFF).
It is estimated four million Australians experience a mental health disorder ever year, and almost half of all Australians will be affected at some point in their lifetime. Depression, anxiety, and substance use disorders are the most common mental illnesses affecting Australians. Not all patients achieve good results from standard treatments, and few new medications have become available in recent years.
However, there is growing evidence that substances such as psilocybin, and 3,4-Methylenedioxymethamphetamine (MDMA), dimethyltryptamine (DMT), and cannabidiol (CBD) when used in a controlled environment and supported by psychological/ psychiatric care, may help treat mental illness that has not responded to other treatments.
The seven projects awarded funding under the Government’s Innovative Therapies for Mental Illness Grant will accelerate global efforts to find new treatments for mental illness by supporting Australian-led research into the safety and efficacy of these drugs compared to standard therapies when used in controlled conditions and accompanied by psychotherapy.
The trials have the potential to provide breakthrough treatment for people suffering from persistent mental illness including major depression with alcohol use, anorexia nervosa, post-traumatic stress disorder (PTSD) and anxiety disorders.
The largest of the grants, more than $3.8 million, will go to a research team at the University of Melbourne for a trial of MDMA-assisted psychotherapy for treatment resistant social anxiety in young adults with autism spectrum disorder. Social anxiety is common in young adults with autism and adds to their disability and distress. Current treatments are often ineffective.
Other trials will use psilocybin for anorexia nervosa, depression and alcohol use; MDMA for alcoholism and post-traumatic stress disorder; CBD for anxiety disorders in youth; and DMT for major depression and alcohol use.
All the trials are subject to regulatory approvals, including additional approval requirements from states and territories for the use of these drugs.
Minister for Health and Aged Care, Greg Hunt, said the Government’s MRFF is helping ensure that Australia’s medical research sector remains at the forefront of global innovation.
“It is vital that we continue to support the search for new and better treatments for mental illness. This funding will boost local research into potentially life-saving therapies and offers hope all those suffering from mental illness,” Minister Hunt said.
Assistant Minister to the Prime Minister for Mental Health and Suicide Prevention, David Coleman, said mental health and suicide prevention is one of the Government’s highest priorities.
“The prevalence and impact of mental illness is devastating for individuals, families and communities. This research is about ensuring that we explore every avenue of potential treatment for Australians diagnosed with a mental illness,” Assistant Minister Coleman said.
The Government’s Medical Research Future Fund is a $20 billion endowment fund, providing sustainable support for Australia’s best and brightest researchers. Further information about the Medical Research Future Fund is available at www.health.gov.au/mrff
National Cabinet Statement
National Cabinet met today to discuss our response to COVID-19 and the Omicron variant, new approaches to test, trace isolate and quarantine including the use of rapid antigen tests (RATs) and the vaccine rollout and booster programme.
The Chief Medical Officer Professor Paul Kelly provided an update on the spread of the Omicron variant. Omicron case numbers continue to increase in Australia and globally. Omicron continues to show greater infectivity than the Delta variant, but with less severity.
Since the beginning of the pandemic there have been 612,106 confirmed cases in Australia and, sadly, 2,289 people have died. More than 56 million tests have been undertaken, with 1,643,841 million tests reported in the past 7 days.
Globally there have been over 294.9 million cases and sadly over 5.4 million deaths, with 2.6 million new cases and 7,169 deaths reported in the last 24 hours. The COVID-19 pandemic continues to surge in many countries around the world.
National Cabinet received a detailed update on Australia’s COVID-19 vaccination program from Lieutenant General John Frewen, Coordinator General of Operation COVID Shield.
Australia’s COVID-19 vaccine roll out continues to expand. To date 43 million doses of COVID-19 vaccines have been administered in Australia, including 212,497 in the previous 24 hours.
In the previous 7 days, more than 754,500 vaccines have been administered in Australia. More than 94.5 per cent of the Australian population aged 16 years and over have now had a first dose of a COVID-19 vaccine, including 98.7 per cent of Australians aged 50 years of age and over and more than 99 per cent of Australians aged 70 years of age and over.
More than 91.6 per cent of Australians aged 16 years and over are now fully vaccinated including more than 96.8 per cent of Australians aged 50 years of age and over and more than 99 per cent of Australians aged 70 years of age and over.
Over 2.7 million booster doses have been administered. Australia has sufficient supplies of boosters, with nearly 18 million mRNA vaccines in stock in Australia. Yesterday, over 176,000 boosters were administered across Australia. Following the widening of eligibility for boosters on 4 January to those who had their second dose at least four months earlier, over 33.8 per cent of those eligible for boosters have had a booster and 28.6 per cent of Australians aged 70 years of age and over have had a booster in the last 8 weeks since the booster program commenced.
National Cabinet will meet again on Thursday 13 January 2022.
Rapid Antigen Tests
National Cabinet noted that COVID-19 tests are free and available at state testing clinics for people who have symptoms or are a close contact.
National Cabinet agreed that up to 10 Rapid Antigen Tests over three months (a maximum of 5 in a month) will be made available free through pharmacies to people holding the following cards:
- Pension Concession Card
- Commonwealth Seniors Health Care Card
- Department of Veterans’ Affairs Gold, White or Orange Card
- Health Care Card
- Low Income Health Card
These free tests will become available in the next two weeks. However, anyone with COVID-19 symptoms and close contacts should attend a state clinic for free testing and not go to a pharmacy to receive a free test. Costs for providing these tests will be shared 50:50 between the Commonwealth and the States and Territories consistent with COVID shared funding agreements.
National Cabinet noted the Commonwealth will provide 10 million RATs to states and territories (a combination of predominantly Point of Care Tests and self tests) to assist with testing and laboratory capacity. National Cabinet agreed to fund these in line with the existing National Partnership Agreement on the COVID-19 Response.
National Cabinet received a briefing from Joe Buffone, Director-General of Emergency Management Australia, on behalf of the National Coordination Mechanism (NCM). Supply chain issues continue to be one of the main disruptors of broad access to RATs. National Cabinet noted that the Commonwealth is working through the NCM to finalise anti-hoarding measures with the Pharmacy Guild of Australia and other major retailers that stock RATs to limit the number of RATs available for sale to each individual.
National Cabinet noted the Commonwealth will prohibit price gouging of and the non-commercial export of RATs, similar to actions taken earlier in the pandemic relating to essential goods such as masks, other PPE and hand sanitiser. As was the case previously, price gouging will be defined as supplying or offering to supply essential goods at a price that is more than 120% of the initial purchase price (a 20% markup) and penalties for not complying with this direction will range up to five years imprisonment or $66,000.
Changes to testing requirements
National Cabinet agreed changes to testing requirements for all states except for Western Australia including:
- Removing the requirement for truck drivers to have rolling seven days tests.
- Testing will not be required before patients present to hospital.
- Confirmation PCR test will not be required after a positive RAT. Individual states and territories will provide further information on how a positive RAT will be recorded. Anyone who tests positive is encouraged to contact their GP for support as required.
- Testing before interstate travel will no longer be required except for Queensland, Tasmania and Western Australia, with Queensland and Tasmania to review these requirements in the coming weeks. State testing clinics will not be able to be used for interstate travel purposes.
- A second post arrival test for international travelers will not be required except for Queensland, who will review this requirement when they reach 90 per cent double vaccination rate.
Workplace Health and Safety
National Cabinet noted the impact on business of current state workplace Health and Safety laws that could imply requiring employees to return a negative RAT test in order to present to work. National Cabinet agreed the Commonwealth Attorney General will convene a meeting of relevant ministers from all jurisdictions to consider workplace health and safety requirements with a view to removing any potential obligation to impose testing requirements in workplaces on employees
National Return to School Framework
National Cabinet tasked the First Secretaries Group (FSG) let by Mr Phil Gaetjens, Secretary of the Department of Prime Minister and Cabinet to develop a national framework to enable students to return to school on day one of term one, and for schools to stay open with consistent requirements across all jurisdictions to be in place prior to the first day of the first term of school. The FSG will report back to National Cabinet at the next meeting.
Driver allegedly caught almost six times over the legal limit – Cessnock
A man has been charged with high-range drink driving after allegedly being caught almost six times over the legal limit in the Hunter region today.
About 1.30pm (Thursday 6 January 2022), officers attached to Hunter Valley Traffic and Highway Patrol Command stopped the driver of a Mitsubishi SUV on Wollombi Road at Bellbird, for the purpose of a random breath test.
Police spoke to the driver and sole occupant of the vehicle – a 41-year-old man – before he was subjected to a roadside breath test, which returned a positive result.
The Cessnock man was arrested and taken to Cessnock Police Station, where a subsequent breath analysis returned an alleged reading of 0.297.
He was charged with high-range PCA, his driver’s licence was confiscated and immediately suspended, and his vehicle was seized.
The man was granted conditional bail and is due to appear at Cessnock Local Court on Wednesday 9 February 2022.
Investigation underway into fatal stabbing – Jesmond
An investigation is underway after a man was fatally stabbed in the Hunter Region yesterday.
About 3.45pm (Thursday 6 January 2022), emergency services were called to a home on Michael Street, Jesmond, following reports a man had been stabbed.
Officers attached to Newcastle City Police District attended and located a 34-year-old man suffering a stab wound to his chest.
Police have been told the man attended the home and was injured during an altercation with a male occupant, who then fled.
The injured man was treated by NSW Ambulance paramedics, before being taken to John Hunter Hospital in a critical condition.
Despite the efforts of medical staff, the man died in hospital.
Newcastle City Detectives have established Strike Force Mantillus to investigate the circumstances of the man’s death.
As part of their inquiries, a large-scale search is also underway to locate the male occupant.
$5.5 million for clinical trials to treat low-survival breast cancers
Two clinical trials which could save lives through new therapies to treat breast cancers that have low rates of survival have been funded, thanks to the Morrison Government.
Tragically, young women diagnosed with breast cancer have a higher rate of recurrence and death from the disease.
To combat this, researchers at the University of Melbourne have conducted a genomic analysis of breast cancer samples from women under 45 years of age. They have identified a new drug target that may improve the prognosis for these young women.
The Morrison Government is directing more than $4.9 million to the researchers to evaluate these new therapies in a clinical trial.
In addition, researchers at the University of New South Wales have turned their attention to treatment resistant triple-negative breast cancer, where new therapies are urgently needed to improve survival rates.
The researchers discovered that blocking what’s called an androgen receptor prevents and treats chemotherapy-resistant triple-negative breast cancer. Pre-clinical models have shown that, when combined with chemotherapy, overall survival rates are significantly improved.
The researchers will use almost $670,000 in Government funding to test this new therapy in a clinical trial.
The funding for both of these trials has been provided through the Medical Research Future Fund’s (MRFF) Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) clinical trials initiative.
There are limited effective treatment options for many rare cancers and diseases, and the combined health burden is significant.
Through RCRDUN, the Government is increasing trial activity in Australia, supporting high quality research and encouraging novel and innovative treatments.
The two projects announced today are a small part of the 2021 RCRDUN grant program. A further 6 streams are being assessed and recipients will be announced in due course.
The $20 billion MRFF is a long-term investment supporting Australia’s best and brightest researchers. Further information about the MRFF is available at www.health.gov.au/mrff
MRFF 2021 Clinical Trials Activity – Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) Grant Opportunity – Stream 2
Project | Recipient | Funding |
4CAST: A phase I/II study evaluating the safety and efficacy of VT-464 in combination with chemotherapy in patients with metastatic breast cancer | University of New South Wales | $668,444.00 |
Addressing the poor outcomes of young women with hormone receptor-positive, HER2-negative (HR+HER2-) early breast cancer | University of Melbourne | $4,909,215.00 |
Total | $5,577,659.00 |